LCDX (Caliber Imaging & Diagnostics) 3-Year RORE % : 0.00% (As of Mar. 2014)


What is Caliber Imaging & Diagnostics 3-Year RORE %?

Caliber Imaging & Diagnostics LCDX 3-Year RORE % is 0.00 as of Mar. 2014.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Caliber Imaging & Diagnostics's 3-Year RORE % for the quarter that ended in Mar. 2014 was 0.00%.

The industry rank for Caliber Imaging & Diagnostics's 3-Year RORE % or its related term are showing as below:

LCDX's 3-Year RORE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -4.17
* Ranked among companies with meaningful 3-Year RORE % only.

Caliber Imaging & Diagnostics  (OTCPK:LCDX) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Caliber Imaging & Diagnostics 3-Year RORE % Related Terms


Caliber Imaging & Diagnostics 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Caliber Imaging & Diagnostics's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caliber Imaging & Diagnostics 3-Year RORE % Chart

Caliber Imaging & Diagnostics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
3-Year RORE %
0.00 0.00 0.00 0.00 0.00

Caliber Imaging & Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LCDX vs VICA, CRVW, RSLS: 3-Year RORE % Comparison

For the Medical Devices subindustry, Caliber Imaging & Diagnostics's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caliber Imaging & Diagnostics 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Caliber Imaging & Diagnostics's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Caliber Imaging & Diagnostics's 3-Year RORE % falls into.



Caliber Imaging & Diagnostics 3-Year RORE % Calculation

Caliber Imaging & Diagnostics's 3-Year RORE % for the quarter that ended in Mar. 2014 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.74--3.721 )/( -5.381-0 )
=2.981/-5.381
=-55.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2014 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 0.00 mean?
Caliber Imaging & Diagnostics (LCDX) has a 3-Year RORE % of 0.00 as of Mar. 2014. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Caliber Imaging & Diagnostics and its competitors.
Is Caliber Imaging & Diagnostics' 3-Year RORE % too high?
Caliber Imaging & Diagnostics' current 3-Year RORE % is 0.00.
How does Caliber Imaging & Diagnostics' 3-Year RORE % compare to VICA and CRVW?
Caliber Imaging & Diagnostics' 3-Year RORE % of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Caliber Imaging & Diagnostics and its competitors. Caliber Imaging & Diagnostics's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caliber Imaging & Diagnostics stock overvalued right now?
Caliber Imaging & Diagnostics (LCDX) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Caliber Imaging & Diagnostics (LCDX), the current 3-Year RORE % is 0.00 as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caliber Imaging & Diagnostics Business Description

Address 50 Methodist Hill Drive, Suite 1000, Rochester, NY, USA, 14623
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.